Leqvio 284 MG/1.5 ML syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DR26FT4EB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,705
Award facts
- Contract value 100% obligated
- $14,704.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,704.62 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 mL syringes on November 20, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LEQVIO is a prescription medication used to lower cholesterol levels, reflecting the ongoing federal medical supply requirements for pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through consistent competitive awards across diverse medical product categories.
Quick answers
Who was awarded contract SPE2DR26FT4EB?
SPE2DR26FT4EB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FT4EB worth?
The government has obligated $14,705 on SPE2DR26FT4EB.
Is contract SPE2DR26FT4EB an order under another contract?
Yes. SPE2DR26FT4EB is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4EB competed?
The extent of competition for SPE2DR26FT4EB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award